[1] |
WANG Sisi, XIE Shuangshuang, MENG Yuexiu, ZHANG Xiangyun, LIU Yunchun.
The diagnostic value of TIM-3 and GATA-3 levels in maternal blood and amniotic fluid for premature rupture of membranes complicated with intrauterine infection
[J]. Tianjin Medical Journal, 2023, 51(3): 315-319.
|
[2] |
CHAI Xiaobing, ZHANG Li, CHU Feifei, WU Huili.
The mechanism of m6A recognition protein HuR inhibiting the growth of colorectal cancer by regulating lncRNA TRG-AS1
[J]. Tianjin Medical Journal, 2023, 51(2): 124-130.
|
[3] |
XIAO Qiuping, ZHAO Chang, LIU Duanyong, LI Shanshan, SHI Min, CHEN Liling, ZHONG Youbao.
Study on mechanism of Bupi Yichang pill in alleviating experimental ulcerative colitis by restoring the homeostasis of CD4+T cell subpopulations
[J]. Tianjin Medical Journal, 2023, 51(12): 1332-1338.
|
[4] |
WANG Mengxiao, WANG Aidi, YANG Wuxia, LIU Baoshan△.
Study on the drug serum of Xijiao Dihuang Combined Prescription regulating Teff/Treg differentiation and function in ITP patients
[J]. Tianjin Medical Journal, 2022, 50(5): 487-492.
|
[5] |
WANG Qiang, KUANG Shixiang, LI Ruozhao, LOU Jinbo, QIAN Yijia, YONG Bo, LIU Yunquan.
Exploration on the regulation mechanism of Bupi Qiangli compound in immune system balance of EAMG rats based on HPTT axis
[J]. Tianjin Medical Journal, 2022, 50(10): 1031-1036.
|
[6] |
LI Yan, ZHANG Jing-nan, ZHANG Jin, SHI Wen-hua, YE Shu-mei, DENG Xiu-ling, HU Rui-ping, XUE Hui-ting.
Cytotoxic effects of spiruline platensis polysaccharides on acute T lymphocyte leukemia
[J]. Tianjin Medical Journal, 2021, 49(4): 337-341.
|
[7] |
CHEN Xi, QUE Yu-kang, XU Sheng-lin, WANG Hao, WANG Yuan, CAI A-wei, HU Yong△.
Clinical study of segmental resection combined with allogeneic bone transplantation in giant cell tumors of bone around knee joint
[J]. Tianjin Medical Journal, 2021, 49(1): 89-93.
|
[8] |
XIAO Wei-mian, ZHA Xu-shan△, WANG You-fa.
Effects of paeonol on expressions of SP, NK1R and mast cell activation in eczema model mice
[J]. Tianjin Medical Journal, 2020, 48(9): 824-828.
|
[9] |
LIN Min-qing, XIA Wen-guang, XU Bo, XU Ai-ping, WANG Ye-ming△.
Clinical Significance of T-Lymphocyte Subsets in the Treatment of COVID-19
[J]. Tianjin Medical Journal, 2020, 48(6): 499-503.
|
[10] |
MU Juan, LYU Hai-rong, LI Jing-yi, JIANG Yan-yu, ZHANG Rui, MENG Juan-xia, YUAN Ting , DENG Qi.
CD22 CAR-T salvage therapy for a refractory acute B lymphocytic leukemia patient with TP53#br#
positive mutation and short-term recurrence after remission from CD19 CAR-T therapy #br#
[J]. Tianjin Medical Journal, 2020, 48(4): 308-312.
|
[11] |
YOU Xiang-yun, , XIANG Zhen-dong, YI Cheng, ZHANG Man, YU Jun-feng△.
Advances in the treatment of prostate cancer by chimeric antigen receptor modified T cells
[J]. Tianjin Medical Journal, 2020, 48(10): 1020-1024.
|
[12] |
ZHAO Pei-qi, ZHANG Hui-lai.
Research progress of chimeric antigen receptor T cell immunotherapy in
B-cell non-Hodgkin lymphoma
[J]. Tianjin Medical Journal, 2020, 48(1): 71-75.
|
[13] |
WANG Kai, GAO Wei.
Role of donor specific regulatory T cells in immune tolerance after liver transplantation
[J]. Tianjin Medical Journal, 2019, 47(11): 1196-1200.
|
[14] |
ZHANG Xi-you, LI Dan-dan, CHEN Feng, SONG Qing-kun, ZHONG Xiao-song.
The efficacy of chimeric antigen receptor T-cell immunotherapy in B-cell lymphoma: Meta-analysis
[J]. Tianjin Medical Journal, 2018, 46(12): 1330-1335.
|
[15] |
ZHANG Shan, SONG Xin-long, WANG Ai-di, XIE Dong-jie, ZHANG Le, LIU Bao-shan△.
The research development of CD4+ T cells and their molecular regulatory
mechanism in aplastic anemia
[J]. Tianjin Med J, 2018, 46(10): 1123-1126.
|